Key facts
- Notable investors include LBBW Venture Capital, Bernhard Arnold, ICIG Ventures, Wolfgang Klein.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Licit Solutions
- ·The full record, as it builds
Funding rounds
No funding rounds for Licit Solutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Licit Solutions
Developer of innovative biocidal substances designed to enhance safety and efficacy in microbial control applications. The company offers propylene diamine derivative substance with a comprehensive antimicrobial effect and inhibits functional proteins, such as enzymes, novel mode of action, broad antimicrobial activity, and a low toxicity profile, enabling biocidal industry to get an alternative to traditional fixatives containing the biocide formaldehyde.
- Sector
- Materials and Resources
- HQ
- Tübingen, Germany
- Founded
- 2024
- Employees
- 18
- Website
- licit-solutions.de/
- Ownership
- Privately Held (backing)
Licit Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Licit Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Licit Solutions in its N-PORT filings yet. We sweep new filings monthly.